Source: Eur Respir J 2011; 37: 1293-1295
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Trzepizur W., Priou P., Paris A., Nardi J., Tual-Chalot S., Meslier N., Urban T., Andriantsitohaina R., Martinez M.C., Gagnadoux F.. Nocturnal release of leukocyte-derived microparticles in males with obstructive sleep apnoea. Eur Respir J 2011; 37: 1293-1295

Member's Comments

No comment yet.

Related content which might interest you: Circadian rythm of circulating microparticles in patients with obstructive sleep apnea Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases Year: 2011 Catecholamine secretion in obstructive sleep apnoea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 38s Year: 2005 Erythrocyte production in obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 692s Year: 2004 Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea Source: Eur Respir J 2009; 33: 574-580 Year: 2009 Microparticles and vascular dysfunction in obstructive sleep apnoea Source: Eur Respir J 2014; 44: 207-216 Year: 2014 Diagnosing excessive daytime sleepiness in obstructive sleep apnoea Source: 5th Sleep and Breathing Conference Year: 2019 Leptin in obstructive sleep apnea Source: Eur Respir J 2001; 18: Suppl. 33, 333s Year: 2001 Circulating microparticles and endothelial dysfunction in obstructive sleep apnea syndrome Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 The velumount device for obstructive sleep apnoea Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009 Vasoconstriction during the night in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 419s Year: 2006 Cortisol metabolism in obstructive sleep apnea (OSA) Source: Eur Respir J 2002; 20: Suppl. 38, 215s Year: 2002 Daytime hypercapnia in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 493s Year: 2002 Awakening headaches are associated with obstructive sleep apnea Source: Eur Respir J 2002; 20: Suppl. 38, 452s Year: 2002 The vascular micromilieu in obstructive sleep apnoea Source: Eur Respir J 2005; 25: 780-782 Year: 2005 Change in PLMS after treatment of obstructive sleep apnea Source: Eur Respir J 2007; 30: Suppl. 51, 593s Year: 2007 Pathophysiological consequences of obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021 Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Sleep and Breathing Conference 2021 Year: 2021 The effect of theophylline and CPAP on cytokine release in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 216s Year: 2006 Prevalance of daytime hypercapnia in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 574s Year: 2002